14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $27.14 $33.02 Tuesday, 23rd Apr 2024 AGIO stock ended at $31.81. This is 5.30% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 8.62% from a day low at $30.40 to a day high of $33.02.
90 days $21.18 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Jul 07, 2023 $27.16 $27.55 $26.63 $26.68 289 019
Jul 06, 2023 $27.31 $27.31 $26.75 $27.03 251 515
Jul 05, 2023 $28.09 $28.43 $27.42 $27.47 284 221
Jul 03, 2023 $28.12 $28.65 $27.92 $28.18 202 805
Jun 30, 2023 $27.85 $28.70 $27.65 $28.32 509 775
Jun 29, 2023 $29.17 $29.17 $27.38 $27.45 707 736
Jun 28, 2023 $28.11 $29.23 $28.00 $29.19 795 215
Jun 27, 2023 $27.92 $28.28 $27.18 $28.13 496 691
Jun 26, 2023 $27.06 $27.75 $26.15 $27.47 756 052
Jun 23, 2023 $26.61 $26.91 $26.22 $26.80 606 676
Jun 22, 2023 $26.87 $27.20 $26.48 $26.93 321 946
Jun 21, 2023 $26.28 $27.33 $26.22 $26.98 322 112
Jun 20, 2023 $25.72 $26.66 $25.28 $26.46 605 376
Jun 16, 2023 $26.23 $26.23 $25.57 $25.78 1 169 159
Jun 15, 2023 $25.55 $25.90 $25.15 $25.81 470 018
Jun 14, 2023 $26.56 $26.96 $25.25 $25.73 399 247
Jun 13, 2023 $26.24 $26.77 $26.01 $26.56 359 278
Jun 12, 2023 $25.90 $26.23 $25.19 $26.08 425 025
Jun 09, 2023 $26.71 $26.71 $25.87 $25.87 208 077
Jun 08, 2023 $26.92 $27.11 $26.16 $26.60 381 080
Jun 07, 2023 $26.98 $27.21 $26.37 $27.03 367 512
Jun 06, 2023 $26.05 $26.98 $26.05 $26.82 359 043
Jun 05, 2023 $25.95 $26.90 $25.89 $26.06 561 866
Jun 02, 2023 $25.96 $26.29 $25.50 $26.05 370 433
Jun 01, 2023 $25.30 $25.87 $24.99 $25.71 206 436
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT